From April 1, 2022 to April 12, 2022, the company has repurchased 6,907,500 shares, representing 0.45% for ¥24,992.96 million. With this, the company has completed the repurchase of 29,376,900 shares, representing 1.88% for ¥99,965.66 million under the buyback announced on October 28, 2021.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4,090 JPY | -0.85% | -1.49% | +0.91% |
04-30 | Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion | RE |
04-26 | EU Panel Backs Approval of Takeda’s Colorectal Cancer Drug | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.91% | 42.03B | |
+31.52% | 690B | |
+21.96% | 546B | |
-5.21% | 358B | |
+17.02% | 323B | |
+5.01% | 287B | |
+13.68% | 235B | |
+3.81% | 199B | |
-10.63% | 195B | |
+3.98% | 161B |
- Stock Market
- Equities
- 4502 Stock
- News Takeda Pharmaceutical Company Limited
- Tranche Update on Takeda Pharmaceutical Company Limited's Equity Buyback Plan announced on October 28, 2021.